Physician attitudes toward industry: A view across the specialties

Archives of Surgery

Volumn 145, Issue 6, 2010, Pages 570-577

  Korenstein, Deborah ^a   Keyhani, Salomeh ^a,b   Ross, Joseph S ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; FUNDING; HEALTH SURVEY; HUMAN; PHYSICIAN ATTITUDE; POLICY; PRIORITY JOURNAL; RESIDENCY EDUCATION; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADULT; ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; EQUIPMENT AND SUPPLIES; ETHICS, MEDICAL; FEMALE; GENERAL SURGERY; GIFT GIVING; HUMANS; INTERPROFESSIONAL RELATIONS; MALE; MARKETING; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEW YORK CITY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; TOTAL QUALITY MANAGEMENT;

EID: 77953828576     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2010.75     Document Type: Article

References (30)

1. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750.
2. Bellin M, McCarthy S, Drevlow L, Pierach C. Medical students' exposure to pharmaceutical industry marketing: a survey at one US medical school. Acad Med. 2004;79(11):1041-1045.
3. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006; 295(4):429-433.
4. Studdert DM, Mello M, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry - self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351(18):1891-1900.
5. Ross JS, Lackner JE, Lurie P, Gross CP, Wolfe S, Krumholz H. Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota. JAMA. 2007;297(11):1216-1223.
6. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? a survey of physicians. Arch Intern Med. 2003;163(18):2213-2218.
7. Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81(7):595-602.
8. Steinman MA, Shlipak MG, McPhee S. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551-557.
9. Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med. 2004;79(11):1046-1050.
10. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294(9):1034-1042.
11. Hopper JA, Speece MW, Musial J. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med. 1997;12(10):639-642.
12. Turton FE, Snyder L. Physician-industry relations. Ann Intern Med. 2007;146(6):469-471.
13. American College of Surgeons. Chapter Guidebook. Chicago, IL: American College of Surgeons; 2005:92-94.
14. Greenberg JA, Norwitz ER. Relationships with industry. Rev Obstet Gynecol. 2008;1(2):47.
15. American Academy of Orthopaedic Surgeons and American Association of Orthopaedic Surgeons. Standards of Professionalism on Orthopaedist-Industry Conflicts of Interest. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2007.
16. Principles, Policies and Procedures for Managing Conflicts of Interest: AUA Conflicts of Interest Policies document - October 2008. American Urological Association Web site. http://www.auanet.org/content/education-and-meetings/ disclosures/COI/policy.pdf. Accessed March 18, 2010.
17. Revised statement on health care industry representatives in the operating room. Bull Am Coll Surg. 2005;90(9):27-28.
18. Iserson KV, Cerfolio RJ, Sade RM. Politely refuse the pen and note pad: gifts from industry to physicians harm patients. Ann Thorac Surg. 2007;84(4):1077-1084.
19. Sufrin CB, Ross JS. Pharmaceutical industry marketing: understanding its impact on women's health. Obstet Gynecol Surv. 2008;63(9):585-596.
20. Epps CHJ Jr. Ethical guidelines for orthopaedists and industry. Clin Orthop Relat Res. 2003;412(412):14-20.
21. Kluger J. Is drug-company money tainting medical education? Time Web site. March 6, 2009. http://www.time.com/time/health/article/0,8599,1883449,00. html. Accessed March 18, 2010.
22. Spurgeon D. New York Times reveals payments to doctors by drug firms. BMJ. 2007;334(7595):655. doi:10.1136/bmj.39167.423738.DB.
23. Harris G. Crackdown on doctors who take kickbacks. New York Times. March 4, 2009: A14.
24. Lo B, Field MJ. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: Committee on Conflict of Interest in Medical Research, Education, and Practice, Institute of Medicine; 2009.
25. Hearings Before the Office of Counsel to the Inspector General, US Department of Health and Human Services, Senate Special Committee on Aging, 110th Cong, 2nd Sess (2008) (testimony of Gregory E. Demske).
26. Harris G. 3 researchers at Harvard are named in subpoena. New York Times. March 28, 2009: A9.
27. Fitz MM, Homan D, Reddy S, Griffith CH III, Baker E, Simpson KP. The hidden curriculum: medical students' changing opinions toward the pharmaceutical industry. Acad Med. 2007;82(10)(suppl):S1-S3.
28. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286(16):1994-1999. (Pubitemid 33010218)
29. Healy M. Under the influence: savvy marketing whets our appetite for prescription pharmaceuticals. Los Angeles Times Web site. August 6, 2007. http://articles.latimes.com/2007/aug/06/health/he-drugintro6. Accessed March 22, 2010.
30. Rothman DJ, McDonald WJ, Berkowitz CD, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA. 2009;301(13):1367-1372.